Esperion Therapeutics, Inc. (ESPR)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 354.14M |
| Enterprise value | 538.06M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.66 |
| Price/book (mrq) | 74.89 |
| Enterprise value/revenue | 4.63 |
| Enterprise value/EBITDA | -3.58 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.82 |
| 52-week change 3 | 46.09% |
| S&P500 52-week change 3 | 21.23% |
| 52-week high 3 | 3.4000 |
| 52-week low 3 | 0.7000 |
| 50-day moving average 3 | 2.4732 |
| 200-day moving average 3 | 1.7759 |
Share statistics
| Avg vol (3-month) 3 | 6.3M |
| Avg vol (10-day) 3 | 7.22M |
| Shares outstanding 5 | 189.4M |
| Implied shares outstanding 6 | 189.4M |
| Float 8 | 184.03M |
| % held by insiders 1 | 0.45% |
| % held by institutions 1 | 39.19% |
| Shares short (28 Mar 2024) 4 | 19.92M |
| Short ratio (28 Mar 2024) 4 | 3.13 |
| Short % of float (28 Mar 2024) 4 | 12.02% |
| Short % of shares outstanding (28 Mar 2024) 4 | 10.77% |
| Shares short (prior month 29 Feb 2024) 4 | 16.95M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -179.87% |
| Operating margin (ttm) | -131.37% |
Management effectiveness
| Return on assets (ttm) | -42.86% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 116.33M |
| Revenue per share (ttm) | 1.13 |
| Quarterly revenue growth (yoy) | 71.40% |
| Gross profit (ttm) | N/A |
| EBITDA | -155.4M |
| Net income avi to common (ttm) | -209.25M |
| Diluted EPS (ttm) | -2.0300 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 82.25M |
| Total cash per share (mrq) | 0.44 |
| Total debt (mrq) | 540.95M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 1.29 |
| Book value per share (mrq) | -3.85 |
Cash flow statement
| Operating cash flow (ttm) | -135.49M |
| Levered free cash flow (ttm) | -107.14M |
© 2024 Yahoo. All rights reserved.